1.Hyalinizing clear cell carcinoma of the salivary gland in an elderly female: A case report supported by EWSR1 molecular studies.
Ariane Marielle F. VALLE ; Jose Louie D. REMOTIGUE ; Erick Martin H. YTURRALDE ; Jose M. CARNATE JR.
Acta Medica Philippina 2025;59(5):88-91
Hyalinizing clear cell carcinoma of the salivary gland is a rare neoplasm, accounting for only less than 1% of malignancies arising from the salivary gland. It is molecularly defined by the expression of the EWSR-ATF1 fusion oncogene. To date, there has been no previous studies published yet in the Philippines regarding the existence of this tumor. In this paper, we present a case of a 70-year-old elderly female who had a 10-year history of a gradually enlarging left lateral neck mass. Histopathologic examination showed a tumor arranged of cords, nests, and trabeculae of monomorphic round cells with abundant clear to lightly eosinophilic cytoplasm surrounded by thick hyalinized collagen bundles. Immunohistochemistry and molecular studies were done which revealed a positive p63 staining, negative SMA and S100, and an EWSR1 rearrangement in Fluorescence in situ hybridization (FISH), thus, confirming the diagnosis.
Human ; Female ; Aged: 65-79 Yrs Old ; Carcinoma ; Immunohistochemistry
2.Warthin-like variant of mucoepidermoid carcinoma of the parotid gland
Krystal April Joy O. Curso ; John Carlo B. Reyes ; Jonathan P. Rivera ; Jose M. Carnate, Jr.
Philippine Journal of Otolaryngology Head and Neck Surgery 2024;39(1):55-57
A 57-year-old woman with a 2-year history of a left infra-auricular mass with no associated symptoms presented with a 6.0 cm ´ 4.0 cm ´ 3.0 cm firm, non-tender, movable mass. No imaging was done. Fine needle aspiration biopsy (FNAB) revealed sheets of epithelial cells that had abundant dense grayish-blue cytoplasm in a mucinous background with abundant lymphocytes (Figure 1), suggestive of salivary gland neoplasm with oncocytic or oncocytoid features (Category IVB, Salivary Gland Neoplasm of Uncertain Malignant Potential).Total parotidectomy revealed a 4.3 X 3.2 X 3.0 cm deep lobe lesion with a tan-grey to dark brown, smooth and dull external surface. Cut sections showed a cream-white to pink, lobulated, heterogenous cut surfaces. Microscopically, the lesion was unencapsulated with poorly demarcated borders. The neoplastic cells were arranged in haphazard sheets and surrounded by abundant lymphocytes. The tumor cells had abundant eosinophilic and granular cytoplasm compatible with oncocytes with mild to moderate nuclear atypia. There were occasional cystic spaces that contained mucin though mucocytes were not readily apparent. (Figure 2) Necrosis, perineural and lymphovascular space invasion or anaplasia were not evident.
Carcinoma, Mucoepidermoid
;
Salivary Gland Neoplasms
;
Parotid Gland
3.Hyalinizing clear cell carcinoma of the salivary gland in an elderly female: A case report supported by EWSR1 molecular studies
Ariane Marielle F. Valle ; Jose Louie D. Remotigue ; Erick Martin H. Yturralde ; Jose M. Carnate Jr.
Acta Medica Philippina 2024;58(Early Access 2024):1-4
Hyalinizing clear cell carcinoma of the salivary gland is a rare neoplasm, accounting for only less than 1% of malignancies arising from the salivary gland. It is molecularly defined by the expression of the EWSR-ATF1 fusion oncogene. To date, there has been no previous studies published yet in the Philippines regarding the existence of this tumor. In this paper, we present a case of a 70-year-old elderly female who had a 10-year history of a gradually enlarging left lateral neck mass. Histopathologic examination showed a tumor arranged of cords, nests, and trabeculae of monomorphic round cells with abundant clear to lightly eosinophilic cytoplasm surrounded by thick hyalinized collagen bundles. Immunohistochemistry and molecular studies were done which revealed a positive p63 staining, negative SMA and S100, and an EWSR1 rearrangement in Fluorescence in situ hybridization (FISH), thus, confirming the diagnosis.
Carcinoma
4.Convalescent plasma as adjunctive therapy for hospitalized patients with COVID-19:The Co-CLARITY Trial
Deonne Thaddeus V. Gauiran ; Teresita E. Dumagay ; Mark Angelo C. Ang ; Cecile C. Dungog ; Fresthel Monica M. Climacosa ; Sandy Chiong Maganito ; Rachelle N. Alfonso ; Anne Kristine H. Quero ; Josephine Anne C. Lucero ; Carlo Francisco N. Cortez ; Agnes Lorrainne M. Evasan ; Ruby Anne Natividad King ; Francisco M. Heralde III ; Lynn B. Bonifacio ; German J. Castillo, Jr. ; Ivy Mae S. Escasa ; Maria Clariza M. Santos ; Anna Flor G. Malundo ; Alric V. Mondragon ; Saubel Ezreal A. Salamat ; Januario D. Veloso ; Jose M. Carnate, Jr. ; Pedrito Y. Tagayuna ; Jodor A. Lim ; Marissa M. Alejandria ; Ma. Angelina L. Mirasol
Acta Medica Philippina 2024;58(2):5-15
Background and Objective:
Convalescent plasma therapy (CPT) may reduce the risk of disease progression among patients with COVID-19. This study was undertaken to evaluate the efficacy and safety of CPT in preventing ICU admission among hospitalized COVID-19 patients.
Methods:
In this open-label randomized controlled trial, we randomly assigned hospitalized adult patients with
COVID-19 in a 1:1 ratio to receive convalescent plasma as an adjunct to standard of care or standard of care alone. The primary endpoint was ICU admission within first 28 days of enrolment. Primary safety endpoints include rapid deterioration of respiratory or clinical status within four hours of convalescent plasma transfusion and cumulative incidence of serious adverse events during the study period including transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), severe allergic reactions, and transfusion-related infections.
Results:
A total of 22 patients were assigned to receive convalescent plasma as an adjunct to standard of care and 22 to receive standard of care alone. The median time from onset of COVID-19 symptoms to study enrolment was eight days (IQR, 4 to 10). Two patients (9.1%) in the CPT group and one patient (4.5%) in the control group were admitted to the ICU. The primary outcome measure, ICU admission, was not different between the two groups (q-value >0.9). No patient who received convalescent plasma had rapid deterioration of respiratory/clinical status within four hours of transfusion and none developed TRALI, TACO, anaphylaxis, severe allergic reactions, or transfusion-related infections. There was also no significant difference in the secondary outcomes of 28-day mortality (two patients in the CPT group and none in the control group, q-value >0.90), dialysis-free days, vasopressor-free days, and ICU-free days.
Conclusions
Among hospitalized COVID-19 patients, no significant differences were observed in the need for
ICU admission between patients given CPT as adjunct to standard of care and those who received standard of
care alone. Interpretation is limited by early termination of the trial which may have been underpowered to
detect a clinically important difference.
COVID-19
;
COVID-19 Serotherapy
5.Follicular thyroid adenoma with papillary architecture
Philippine Journal of Otolaryngology Head and Neck Surgery 2023;38(1):66-67
A 23-year-old woman underwent left thyroid lobectomy and isthmusectomy for a 2 cm diameter firm mass on the left side of the neck that was also visualized on ultrasonography. The specimen consisted of a 22-gram thyroid gland composed of the left lobe, isthmus and a pyramidal lobe. Cut section of the left lobe showed a 3.5 cm diameter solitary, discrete and encapsulated mass with a tan lobulated and solid cut surface. The rest of the thyroid tissues had red-brown meaty cut surfaces.
Microscopic section shows a follicular-patterned proliferation enclosed by a thin fibrous capsule with frequent Sanderson polster-like papillary excrescences. (Figures 1 and 2) Both the follicular and the papillary structures are lined by cuboidal to columnar follicular epithelial cells that had ample eosinophilic to pale cytoplasm and uniformly sized, minimally enlarged, generally round, and monolayered nuclei without nuclear grooving, folds, pseudoinclusions, and chromatin clearing. There are no mitotic figures seen. Some of the papillary structures have delicate vascular cores. (Figure 3) There are no psammoma bodies noted. The follicles contain variable amounts of pale eosinophilic colloid ranging from colloid-poor crowded follicles to those with ample colloid that have frequent peripheral scalloping. (Figure 4) Exhaustive sections failed to disclose capsular or vascular invasion. Based on the microscopic features, a diagnosis of follicular adenoma with papillary architecture was rendered.
Follicular thyroid carcinoma
;
papillary thyroid carcinoma
6.Epithelial-Myoepithelial carcinoma of the lacrimal gland - Case report and review of literature
Mara Augustine S. Galang ; Gary John V. Mercado ; Armida L. Suller Pansacola ; Jose M. Carnate Jr.
Philippine Journal of Ophthalmology 2023;48(2):91-96
Objective:
To describe the clinicopathologic features and outcome of a patient with epithelial-myoepithelial carcinoma of the lacrimal gland who underwent modified lateral orbitotomy with en toto removal of the lesion and adjuvant radiotherapy.
Methods:
This is a case report.
Results:
A 31-year-old Filipino male seafarer presented with a 2-month history of an enlarging left superotemporal orbital mass and inferonasal displacement of the globe. Magnetic resonance imaging revealed a superotemporal extraconal mass within the lacrimal sac fossa with evidence of osseous infiltration of the superolateral orbital rim. Modified lateral orbitotomy was performed with en toto removal of the lesion and the clinically infiltrated adjacent lateral bony margin. Histopathologic diagnosis of epithelial-myoepithelial carcinoma of the lacrimal gland was made based on the classic and distinct biphasic morphology and was confirmed with immunohistochemistry studies (cytokeratin-7, S-100, and p63). Systemic surveillance using positron emission tomography and computed tomography scan with contrast revealed no evidence of regional or distant metastasis. Adjuvant radiotherapy of the orbital area was performed for increased local control. Twelve months postoperatively, the patient showed no evidence of tumor recurrence.
Conclusion
Epithelial-myoepithelial carcinoma of the lacrimal gland is a rare condition, and this is the first documented case from the Philippines. Accurate diagnosis is necessary for appropriate treatment. It should be included in the differential diagnosis of infiltrative lesions in the lacrimal gland fossa.
Lacrimal Apparatus
7.Application of the Milan System of reporting salivary gland cytopathology: A retrospective cytohistological study in a Tertiary Medical Center
Carolyn Marie Legaspi ; Elizabeth Ann Alcazaren ; Jose Carnate Jr.
Philippine Journal of Pathology 2022;7(1):15-23
Background:
A fine needle aspiration biopsy has been established as a safe, minimally invasive procedure in evaluation of salivary gland lesions. The complex overlapping cytomorphology of these lesions are challenging for pathologists, hence the introduction of an evidence-based system, the Milan System of Reporting Salivary Gland Cytopathology, to improve overall patient care. The study was taken up to reclassify salivary gland lesions from previous FNA biopsies in order to determine sensitivity, specificity, positive and negative predictive values of FNA, and evaluate the risk of malignancy of the various categories of the Milan system.
Methodology:
This was a 6-year retrospective descriptive study in a tertiary medical center. All salivary gland FNA cases were reviewed by two pathologists, and re-classified into the six categories of the Milan System. The number of false positive, false negative, true positive and true negative cases were obtained by comparing with the final histopathology diagnosis, and the risk of malignancy per category were calculated.
Results:
A total of 76 cases were reviewed and the overall average of the two readers diagnostic accuracy were 85.02% (95% CI: 84.50-85.60%), sensitivity and specificity were 80.77% (95% CI: 79.90-81.60%) and 86.19% (95% CI: 85.70-86.70%), respectively; positive and negative predictive values were 62.16% (95% CI: 60.70-63.60%) and 94.17% (95% CI: 94.00-94.40%), respectively.
Conclusion
The Milan System category with highest risk of malignancy was Malignant (Category VI – 100%). FNAB is still a reliable tool for clinicians, and use of the Milan System of Reporting Salivary Gland Cytopathology is beneficial in increasing efficacy of communication among clinicians to improve patient care.
Cytology
;
Salivary Glands
8.Immunohistochemical expression of MDM2 and p16 in adipocytic neoplasms measuring ten centimeters or more in diameter among Filipino patients in a Public Tertiary Hospital from 2017 to 2019
Marvin Masalunga ; Jonathan Rivera ; Jose Carnate Jr.
Philippine Journal of Pathology 2021;6(2):11-21
Introduction:
A size of more than 10 cm suggests that a soft tissue tumor might be malignant. Pertinent ancillary diagnostic testing, such as immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH), may be done to confirm the diagnosis. Several studies have shown that size may be a useful criterion in determining which tumors are candidates for further molecular testing. MDM2 and p16 are IHC markers for atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLPS).
Objectives:
The primary objective of this study is to determine the proportion of tumors signed out as “lipomas” from 2017 to 2019, and measuring at least 10 cm, that express MDM2 and p16 on IHC and warrant revision as ALT/WDLPS.
Methodology:
This is a descriptive, retrospective cohort study in which all lipomas from 2017 to 2019 that measured at least 10 cm were included. The size, age of the patient, and location of each tumor were documented. The slides of all eligible cases were reviewed and immunohistochemically stained for MDM2 and p16. For each case, the intensity and immunoreactivity of each stain were assessed using a modified, four-tier scoring system. Fisher’s exact test was used to determine if a significant number of tumors expressed MDM2 or p16.
Results:
Thirty (30) cases satisfied the inclusion and exclusion criteria. The average size of these tumors is 15.10 cm. There is no sex predilection. The most common location of these tumors is the extremities. None of the tumors expressed MDM2, and only one case was p16-positive. The case positive for p16 also showed cytologic atypia and variability in cell size, resulting in the revision of its diagnosis from lipoma to atypical lipomatous tumor. The rate of diagnosis revision after slide review and IHC studies is 3.33%.
Conclusion
None of the adipocytic tumors that measured at least 10 cm in diameter and were signed out as lipomas was MDM2 positive, and only one case was p16-positive. Thus, morphology remains the cornerstone in the diagnosis of adipocytic tumors. Careful microscopic evaluation is necessary to establish the diagnosis of malignancy in these tumors. Ancillary tests should only be considered in cases where the pathologic features are equivocal.
Neoplasms
;
Adipose Tissue
;
Lipoma
;
Extremities
9.A case of dentinogenic ghost cell tumor
Jon Michael Vincent Soon ; Jose Carnate Jr.
Philippine Journal of Pathology 2021;6(2):38-40
Among the ghost cell lesions, Dentinogenic Ghost Cell Tumors (DGCT) are among the rarest. We report a case of a 45-year-old Filipino man, who presented with a right mandibular mass. Microscopic examination showed a solid neoplasm composed of islands of odontogenic epithelium with areas showing aberrant keratinization forming ghost cells and dentinoid material. We also discuss the pertinent differential diagnosis of ghost cell-containing odontogenic tumors. We report this case due to its rarity, its morphological resemblance to ameloblastoma, and its potential for malignant transformation.
Odontogenic Cysts
;
Odontogenic Tumors
10.Gastric glomus tumor: A case report
Gio Earnest de la Cruz ; Carolyn Marie Legaspi ; Jose Carnate, Jr.
Philippine Journal of Pathology 2021;6(2):55-58
Glomus tumor is an uncommon mesenchymal neoplasm usually described in the distal extremities, and rarely involving visceral organs. We report the case of a 27-year-old Filipino female with a history of low hemoglobin count and a submucosal gastric mass. This was demonstrated on microscopic and immunohistochemical studies to be a gastric glomus tumor (GGT). Although rare, GGTs should be part of the differential diagnoses of submucosal gastric masses.
Glomus Tumor
;
Stomach Neoplasms
;
Immunohistochemistry


Result Analysis
Print
Save
E-mail